Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

LG Life Science Tops R&D Investment List of Korea-Listed Pharmas

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Of the 37 local Korean pharmas listed on Korea's main KOSPI stock market, LG Life Science topped local pharmas in R&D investment last year in both scale and in proportion to its sales, according to a report released by a lawmaker in an Oct. 6 National Assembly session
Advertisement

Related Content

Korea Biosimilar Play LG Life Sciences Names New CEO Amid Unfriendly Business Conditions
LG Life Sciences' 2nd Quarter Sales Dampened By Strong Won, Tightened Regulatory Watch On Pharma
Korea's Boryung Pharma Seeking MNCs To Sell Hypertension Product Abroad
Korea's Boryung Pharma Seeking MNCs To Sell Hypertension Product Abroad
Korea's LG Electronics Teams Up With International Vaccine Institute To Inoculate Kids In Kenya, Ethiopia
Asia's Innovation Horizon: Insiders Are Optimistic And Wary
Leading Korean Pharma Companies Issued Fines In First Court Intervention Case Over Rebates
Gilead Expands Hep C Portfolio With LG Life Sciences Deal
Gilead Expands Hep C Portfolio With LG Life Sciences Deal
Takeda Inks Deal To Develop Anti-Obesity Drugs With LG Life Sciences
Advertisement
UsernamePublicRestriction

Register

SC070248

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel